Pharma Services July 2024

Crosstree BlueBooks provide an executive review of key health sciences transactions, financial movements, and public market activity. BlueBooks also offer a glimpse of how valuations are changing and how recent trends may affect future transactions.

Highlights from this edition:

• BridgeView Life Sciences was acquired by Zensar Technologies
• Exima Research Network, LLC announced its acquisition of Tidewater Clinical Research, Inc.
• Huma Therapeutics closed a $80MM Series A Financing, led by AstraZenca PLC (LSE:AZN), HAT SGR SpA, Leaps by Bayer, Hitachi Ventures GmbH